Publications by authors named "Benjamin Durham"

Claim this Profile
I
Influence of ApoE genotype on doxorubicin-induced cognitive impairment in juvenile rats.
Chadni Patel, Frank Diglio, Benjamin H Durham, Peter D Cole

Sci Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibition.
Eli L Diamond, Jean-Francois Emile, Takeshi Fujino, Julien Haroche, Maxim I Maron, Benjamin H Durham

Cancer Cell· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NTRK1-rearranged histiocytosis: clinicopathologic and molecular features.
Rivers Fragneau, Sylvie Fraitag, Paul G Kemps, Zofia Hélias-Rodzewicz, Somak Roy, Benjamin H Durham

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Pathogenesis of the Histiocytic and Dendritic Cell Neoplasms.
Benjamin H Durham

Hematol Oncol Clin North Am· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inherited resilience to clonal hematopoiesis by modifying stem cell RNA regulation.
Gaurav Agarwal, Mateusz Antoszewski, Xueqin Xie, Yash Pershad, Uma P Arora, Benjamin H Durham

bioRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of methylation on the let-7-BCL2L1-BCL2 axis and the potential use of hypomethylating and BH3 mimetic drugs in histiocytic neoplasms.
Mali Salmon-Divon, Refael Meyuchas, Ofer Shpilberg, Elimelech Okon, Jamal Benhamida, Benjamin H Durham

Leukemia· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies.
Melissa Krystel-Whittemore, Kseniya Petrova-Drus, Ryan N Ptashkin, Mark D Ewalt, JinJuan Yao, Benjamin Durham

Haematologica· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy.
Joshua S Friedman, Benjamin H Durham, Anne S Reiner, Mariko Yabe, Kseniya Petrova-Drus

Br J Haematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell Neoplasms.
Ying Liu, Caleb Ho, Wayne Yu, Ying Huang, Jeffrey Miller, Benjamin Durham

J Mol Diagn· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-Wide Association Study Identifies the First Germline Genetic Variant Associated With Erdheim-Chester Disease.
Javier Martínez-López, Ana Márquez, Francesco Pegoraro, Lourdes Ortiz-Fernández, Marialbert Acosta-Herrera, Benjamin H Durham

Arthritis Rheumatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms.
Benjamin H Durham, Oshrat Hershkovitz-Rokah, Omar Abdel-Wahab, Mariko Yabe, Young Rock Chung

Blood Adv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histiocytic neoplasm subtypes differ in their MAP2K1 mutational type.
Jean-François Emile, Zofia Hélias-Rodzewicz, Benjamin H Durham, Sébastien Héritier, Malik da Silva

Blood Adv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms.
Anne S Reiner, Benjamin H Durham, Mariko Yabe, Kseniya Petrova-Drus, Jasmine H Francis

Br J Haematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell Leukemia.
Jae H Park, Sean Devlin, Benjamin H Durham, Eric S Winer, Scott Huntington

NEJM Evid· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition.
Eli L Diamond, Jasmine H Francis, Mario E Lacouture, Veronica Rotemberg, Mariko Yabe, Benjamin H Durham

Leukemia· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach.
Seyram A Doe-Tetteh, Sabrina Y Camp, Dalicia Reales, Jett Crowdis, Anne Marie Noronha, Benjamin H Durham

Clin Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Detailed Description of the Technical Performance, Clinical Utility, and Platform Comparison.
Kseniya Petrova-Drus, Mustafa Syed, Wayne Yu, Kasey Hutt, Alyssa M Zlotnicki, Benjamin Durham

J Mol Diagn· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First report of bilateral breast-implant associated anaplastic large cell lymphoma caused by identical T-cell clone.
Robert Stuver, Natasha E Lewis, Mark D Ewalt, Ahmet Dogan, Benjamin H Durham

Leuk Lymphoma· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation.
Sisi Chen, Rahul S Vedula, Antonio Cuevas-Navarro, Bin Lu, Simon J Hogg, Benjamin H Durham

Cancer Discov· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axis.
Ran Weissman, Eli L Diamond, Julien Haroche, Benjamin H Durham, Fleur Cohen

Leukemia· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RACGAP1 variants in a sporadic case of CDA III implicate the dysfunction of centralspindlin as the basis of the disease.
Sandeep N Wontakal, Mishan Britto, Huan Zhang, Yongshuai Han, Chengjie Gao, Benjamin H Durham

Blood· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors.
Eric Wang, Xiaoli Mi, Meghan C Thompson, Skye Montoya, Ryan Q Notti, Benjamin H Durham

N Engl J Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.
Paul G Kemps, Jennifer Picarsic, Benjamin H Durham, Zofia Hélias-Rodzewicz, Laura Hiemcke-Jiwa

Blood· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histiocytosis and the nervous system: from diagnosis to targeted therapies.
Fleur Cohen Aubart, Ahmed Idbaih, Jean-François Emile, Zahir Amoura, Omar Abdel-Wahab, Benjamin H Durham

Neuro Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic modulation of RNA splicing enhances anti-tumor immunity.
Sydney X Lu, Emma De Neef, James D Thomas, Erich Sabio, Benoit Rousseau, Benjamin H Durham

Cell· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis